Pasithea Therapeutics News

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Marques Tiago

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Dumesnil Simon

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Schneiderman Daniel H

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Leahy Emer

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Novak Alfred J

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Currie Graeme Martin

Apr 5 21:49 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director STEINMAN LAWRENCE

Apr 5 21:49 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director STEINMAN LAWRENCE

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schneiderman Daniel H

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Novak Alfred J

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Marques Tiago

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dumesnil Simon

Mar 1 21:50 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Currie Graeme Martin

Mar 1 21:50 ET

Pasithea Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Currie Graeme Martin

Jul 3, 2023 17:00 ET

Pasithea Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Lawrence Steinman(6.0%)

Jun 7, 2023 18:29 ET

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director STEINMAN LAWRENCE

Jun 6, 2023 21:01 ET

Pasithea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director STEINMAN LAWRENCE

Jun 6, 2023 21:00 ET

Pasithea Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Paul B. Manning(11.3%),PD Joint Holdings, LLC, Series 2016-A(11.3%), etc.

Feb 14, 2023 18:28 ET

Pasithea Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner PD Joint Holdings, LLC Series 2016-A

Feb 14, 2023 18:15 ET